University of California San Francisco
Give to UCSF
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
Jon Kleen is named the 2023 Dreifuss-Penry Epilepsy Award recipient by the American Academy of Neurology (AAN). He is honored for his contributions to epilepsy treatment.
In a first, UCSF scientists created a molecular-level, 3D picture of how an odor molecule activates a human odorant receptor.
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
Increasing a newborn’s blood pressure after heart surgery may reduce brain injuries and increase survival for infants.
Sleep medications may increase risk of dementia for white people, though the type and amount of medication may also explain the higher probability.
On the operating table and inside the lab of a rising star in cancer neurosurgery.
Could psychedelics become mainstream medicines?
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
While we sleep, our brains process our daily actions to create motor memory, which makes physical acts such as throwing a basketball subconscious.
UCSF Experts Present Research at the Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Francisco.
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
The brains of people with Down syndrome develop the same neurodegenerative tangles and plaques associated with Alzheimer’s disease and frequently demonstrate signs of the neurodegenerative disorder in their forties or fifties. A new study shows that these tangles and plaques are driven by the same amyloid beta (Aß) and tau prions as Alzheimer’s disease.
Brain implants for speech, neurological effects of COVID-19, and motor recovery after stroke are among the topics that researchers from UCSF will be presenting at this year’s annual meeting of the Society for Neuroscience.
A $147 million grant will expand diversity among Alzheimer’s disease research participants, and involve partners from UCSF, the San Francisco VA Medical Center, and the Northern California Institute for Research and Education.
After Don Onken suffered a stroke at 78, a quick response by doctors at the UCSF Medical Center at Parnassus Heights helped him get back on his feet quickly – and back to the golf course.
A small molecule called ISRIB that was identified at UCSF can reverse the neuronal and cognitive effects of concussion in mice weeks after an injury occurred, new research found.
After a decade of work, scientists at UCSF’s Neuroscape Center have developed a suite of video game interventions that improve key aspects of cognition in aging adults.
A new study shows that fewer Black, Hispanic and Asian patients would qualify for these treatments that may slow Alzheimer’s progression, since cognitive impairment in these groups is more likely to be caused by other forms of dementia that may be unrelated to amyloid plaques.
A newly identified set of molecules alleviated pain in mice while avoiding the sedating affect that limits the use of opiates, according to a new study led by researchers at UC San Francisco.
UCSF has revealed how blood vessel cells develop in the prenatal human brain, paving the way to fully understand the role of these cells in healthy brain development and disease.
Scientists have designed compounds that hit the same key receptor that LSD activates without causing hallucinations. A single dose produced powerful antidepressant and antianxiety effects in mice that lasted up to two weeks.
